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Background: There is very limited evidence regarding long-term prognosis of chronic cough. We
examined longitudinal outcomes among patients with chronic cough, and explored predictors of cough
persistence.
Methods: A retrospective cohort was constructed of adults who had newly visited a specialist cough
clinic in 2012e2013. All had undergone systematic investigation for chronic cough. The Hull Airway
Reflux Questionnaire (HARQ) was administered to assess reflux cough symptoms. A follow-up survey
was conducted in 2016e2017 to assess cough persistence.
Results: From 418 candidates, 323 participated in the follow-up study; main analyses focused on patients
with chronic persistent cough (n ¼ 64; 19.8%) and remitted cough (n ¼ 193; 59.8%). Compared with
remitted cough group, chronic persistent cough group had more family history of chronic cough (17.2%
vs. 4.7%, p ¼ 0.001) and cold air-sensitive cough (62.5% vs. 44.6%, p ¼ 0.013). The total HARQ score did not
differ; however, two items (cough with eating and cough with certain foods) scored significantly higher in
chronic persistent cough. In multivariate analyses, a family history of chronic cough (adjusted odds ratio
4.27 [95% confidence interval 1.35e9.89]), cold air-sensitive cough (2.01 [1.09e3.73]), and cough with
eating (1.22 [1.02e1.45]) were associated with chronic persistent cough at 4 years.
Conclusions: Cough persists in about 20% of patients after 4 years following systematic assessment and
treatments. Several cough characteristics, such as family history, cold air-sensitivity, or reflux cough, may
be associated with cough persistence. Larger cohort studies are warranted to further understand long-
term prognosis and confirm predictors of persistence in patients with chronic cough.
Copyright © 2020, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The cough reflex is a physiological mechanism for protecting the
lower airways.1 However, when dysregulated, cough becomes aClinical Immunology, Airway
al Center, University of Ulsan
, Seoul, 05505, South Korea.
).
ety of Allergology.
rgology. Production and hosting by Elsepathologic condition. Cough is one of the most common symptoms
that lead patients to seek a medical consultation.2 In particular,
chronic cough, usually defined as cough persisting for more than 8
weeks,3,4 is a common problem in the general populations and is a
major challenge for patients and clinicians in many clinical set-
tings.5,6 The impact of persistent cough on quality of life is not
confined to the physical domain, but also encompasses psychoso-
cial aspects, frequently leading to social isolation of the affected
individuals.7e9vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
S.-Y. Kang et al. / Allergology International 69 (2020) 588e593 589Despite the importance of chronic cough, however, the long-
term prognosis is largely unknown.10 To our knowledge, only 2
studies so far have described longitudinal outcomes in patients in
European countries.11,12 However, given the heterogeneity of clin-
ical characteristics and methodologies across studies, further
studies are warranted to understand the long-term prognosis of
chronic cough.
In this retrospective cohort study, we examined 4-year longi-
tudinal outcomes in patients who were systematically managed
according to anatomic diagnostic protocols at a tertiary cough
clinic. Our outcomes of interest were: (1) the frequency of cough
persistence, and (2) baseline predictors of cough persistence at 4
years after the first outpatient visit.Methods
Baseline cohort description
A retrospective cohort was constructed with 418 adult patients
with chronic cough who had visited a specialist cough clinic for the
first time at a tertiary hospital in Seoul, Korea, betweenMarch 2012
and December 2013. All patients were assessed and managed ac-
cording to anatomic diagnostic protocols in international guide-
lines for chronic cough.3,4 In their initial visit, participants
underwent investigation for a differential diagnosis, including
chest X-rays, spirometry, methacholine bronchial challenges, or
induced sputum analyses. Chest X-rays and spirometry were per-
formed in all subjects, and other tests were selected at physician's
discretion.
Chest X-rays were interpreted by radiologists and classifled as
abnormal in this study, if any of the following conditions were
reported: pulmonary tuberculosis, pneumonia, emphysema,
bronchiectasis, pulmonary nodules, lung cancer, mediastinal
disease, or other lung parenchymal diseases. Methacholine
bronchial challenge tests assessed airway hyper-responsiveness,
using the modified protocol by Chai et al.13; each individual
inhaled 5 inspiratory capacity breaths while increasing the
methacholine concentration from 0.5 to 16 mg/mL. The meth-
acholine challenge test was considered positive if 16 mg/mL or
lower concentration of methacholine caused a 20% fall in forced
expiratory volume in 1 s (FEV1) from the baseline.14 Induced
sputum analyses were performed according to European Respi-
ratory Society/American Thoracic Society working group report
protocols15; sputum eosinophilia was defined by sputum eosin-
ophils 3%.16 Skin prick tests were performed with 55 common
inhalant allergens in Korea17; a wheal response with 3 mm to
any inhalant allergen compared with negative controls was
considered positive. Capsaicin cough challenge tests were per-
formed to assess cough sensitivity, as previously described.18 The
subjects inhaled 0.5e64 mM of nebulized capsaicin. The number
of coughs within 1 min after each dose was counted. Capsaicin
cough sensitivity was described as the lowest capsaicin concen-
tration (mM) to provoke 2 (C2) and 5 (C5) consecutive coughs
after the inhalation.
Following outcomes were assessed using structured question-
naires. Cold air-sensitive cough was defined by a positive response
to “Is your cough triggered when you inhale cold air?” Family his-
tory of chronic cough was defined by at least 1 parent or sibling
ever having chronic cough. The Korean version of the Hull Airway
Reflux Questionnaire (HARQ) was administered to assess airway
reflux symptoms, which consists of 14 items with a maximum total
score of 70.19Follow-up study
A follow-up study was conducted between October 2016 and
March 2017. Multiple choice questions were utilized to assess
cough activity and persistence as the following: Q1: “Howwas your
cough during the last month, compared to the initial outpatient
visit?” (not troublesome; similarly troublesome; or worse); Q2:
“How long did you suffer from cough during the last 1 year?” (not
troublesome; less than 25%; 25e50%; or more than 50% of the
year); and Q3: “In the last 1 month, have you taken medication to
control your cough?” (yes or no) (Fig. 1). Based on the responses,
participants were classified as having “chronic persistent cough” if
they had current troublesome cough (similarly troublesome or
worse cough as in Q1) that is persistent for longer than 25% of the
last 1 year (Q2). Participants were classified as having “remitted
cough” if they had no troublewith their cough during the last 1 year
(Q1, Q2), with no current needs for medication to control their
cough (Q3). Other patients were classified as “intermediate cough”
subgroups, based on different responses to Q1-Q3. Main analyses
focused on the comparison between chronic persistent cough and
remitted cough patient groups.
In-person interviews were conducted for patients who were
regularly attending the clinic. However, for those who were not
regularly visiting the clinic, a telephone interview was conducted
using the same questionnaire. All interviews were conducted by an
experienced research nurse. Electronic medical records were
reviewed to retrieve cough durations at the baseline visit. All par-
ticipants gave written informed consent (verbal informed consent
in the case of telephone interviews) and the study protocol was
approved by the institutional review board (IRB No.1605-050-760).Statistical analysis
Differences between the 2 main groups (chronic persistent
cough vs. remitted cough) were evaluated by Student's t-test for
continuous variables and by the Chi-squared test for categorical
variables. Capsaicin cough responses as continuous parameters (C2
or C5) were compared after log2 transformation, as they are not
normally distributed. Univariate and multivariate logistic regres-
sion analyses were performed to explore predictors for chronic
persistent cough (vs. remitted cough); multivariate logistic
regression analyses were conducted for parameters with p values
less than 0.1 in the univariate analyses. All statistical analyses were
performed using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA).
Two-sided p values less than 0.05 were considered statistically
significant.Results
Cohort characteristics
From a total of 418 candidates, 323 patients responded to the
follow-up study invitation (overall response rate: 77.3%). Among 53
patients with regular follow-ups to the outpatient clinic, 45
responded to a request for an in-person interview. Among 365
patients without regular follow-ups to the clinic, 278 responded to
a telephone interview survey (Fig. 1). Overall, non-respondents had
significantly more cold air-sensitive cough and chest X-ray abnor-
malities at baseline than respondents; however, there were no
differences in age, sex, body mass index, cough duration, and other
clinical parameters (Supplementary Table 1). The average duration
of follow-ups in the respondents was 3.6 ± 0.5 years.
Fig 1. Flow of patient selection.
Table 1
Comparison of baseline characteristics in patients with chronic persistent cough and
remitted cough patients.
Chronic persistent




Age (years) 54.2 ± 15.0 51.2 ± 15.0 0.17
Sex (female, %) 70.3 69.9 0.96
Body mass index (kg/m2) 24.3 ± 4.1 23.9 ± 3.4 0.50
Smoking status (%) 0.87
Non-smoker 75.0 74.6
Ex-smoker 18.8 18.1
Current smoker 6.3 7.3
Cough duration (months) 70.1 ± 106.1 44.6 ± 72.7 0.080
Family history of chronic
cough (%)
17.2 4.7 0.001
Cold air-sensitive cough (%) 62.5 44.6 0.013
Chest x-ray abnormality (%) 3.1 2.6 1.00
S.-Y. Kang et al. / Allergology International 69 (2020) 588e593590Patients were categorized into “chronic persistent cough”,
“remitted cough”, and “intermediate subgroups”, as described in
Methods. Among a total of 323 respondents, 64 patients (19.8%)
were classified as having “chronic persistent cough” and 193 pa-
tients (59.8%) were classified as having “remitted cough” (Fig. 1).
“Intermediate cough” subgroups (n¼ 66; 20.4%) included: “current
non-persistent cough” (n ¼ 23; current troublesome cough in Q1
but lasting for less than 25% of the last year in Q2); “past non-
persistent cough” (n ¼ 38; no current troublesome cough in Q1
and cough but lasting for less than 25% of the last year in Q2); and
“past persistent cough” (n¼ 5; no current troublesome cough in Q1
but cough lasting for longer than 25% of the last year in Q2). Sub-
sequent analyses were focused on the comparison between chronic
persistent cough and remitted cough patient groups. The flow of
participant selection and classification is summarized in Figure 1.FEV1, % predicted 99.1 ± 18.7 101.0 ± 16.0 0.45
FVC, % predicted 99.1 ± 15.1 101.2 ± 12.6 0.28










Log2 capsaicin C2 (mM) z Median 3 (IQR 2e4) Median 3 (IQR 2e4) 0.29




FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; IQR, interquartile
range.
y Positive airway hyperresponsiveness was defined if the subject had meth-
acholine PC20 (the provocative concentration of methacholine that results in a 20%
drop in FEV1) < 16 mg/mL.
z C2 (or C5) was defined by the lowest capsaicin concentration to provoke 2 (or 5)
consecutive coughs within 1 min after inhalation.Comparison between chronic persistent cough and remitted cough
Baseline characteristics of the 2 patient groups are summarized
in Table 1. Middle-aged female predominance was commonly
observed in both groups. Compared with patients with remitted
cough, patients with chronic persistent cough had more family
history of chronic cough (17.2% vs. 4.7%; p ¼ 0.001), and cold air-
sensitive cough (62.5% vs. 44.6%; p ¼ 0.013). Patients with chronic
persistent cough showed trends toward longer cough duration
(70.1 ± 106.1 vs. 44.6 ± 72.7 months; p ¼ 0.080). However, there
were no significant differences in other parameters, such as body
mass index, smoking history, chest X-ray abnormality, spirometry
parameters, methacholine airway hyper-responsiveness, capsaicin
cough sensitivity (C2 and C5), sputum eosinophilia, or inhalant
allergen skin prick test responses between the 2 groups at baseline.
S.-Y. Kang et al. / Allergology International 69 (2020) 588e593 591Baseline total HARQ score did not significantly differ (30.2± 13.5
vs. 28.1 ± 13.6; p ¼ 0.279); however, 2 items (Q9: “Cough with
eating” [during or soon after meals] and Q10: “Cough with certain
foods”) scored significantly higher in the chronic persistent cough
group than in the remitted cough group (Q9: 2.3 ± 1.8 vs. 1.7 ± 1.6;
p ¼ 0.025, and Q10: 1.7 ± 1.9 vs. 1.1 ± 1.5; p ¼ 0.021) (Table 2).
Exploration of predictors of chronic persistent cough
Univariable logistic regression analyses were conducted to
explore potential predictors of chronic persistent cough (vs.
remitted cough) (Supplementary Table 2). In univariate analyses,
cough duration (year) (odds ratio [OR]: 1.003; [95% confidence in-
terval [CI]: 1.000e1.006]), family history of chronic cough (OR:
4.24; [95% CI 1.67e10.78]), cold air-sensitive cough (OR: 2.07; [95%
CI: 1.16e3.70]), HARQ Q9 (cough with eating) score (OR: 1.23; [95%
CI: 1.04e1.46]) and Q10 (cough with certain foods) score (OR: 1.24;
[95% CI: 1.05e1.45]) were positively associated with chronic
persistent cough. In multivariate logistic regression analyses (vs.
remitted cough; please see Methods for covariate selection), we
found significant associations between chronic persistent cough
and the following baseline parameters: a family history of chronic
cough (adjusted odds ratio [aOR]: 4.27; [95% CI: 1.35e9.89]), cold
air-sensitive cough (aOR: 2.01; [95% CI: 1.09e3.73]) and HARQ Q9
(cough with eating) score (aOR: 1.22; [95% CI: 1.02e1.45]) (Fig. 2).
Discussion
The present retrospective cohort study found that about 20% of
patients had chronic persistent cough about 4 years after system-
atic assessment and management at a tertiary cough clinic. Several
cough characteristics, such as family history of chronic cough, cold
air-sensitive cough, or cough with eating, were positively associ-
ated with cough persistence, suggesting that specific cough char-
acteristics may predict the natural course of chronic cough. These
findings suggest that prospective studies are warranted to confirm
predictors for cough persistence in patients with chronic cough.
In the literature, there are only 2 studies on longitudinal out-
comes and predictors for cough persistence in patients with chronic
cough. Yousaf et al.11 followed up 45 patients with unexplained
chronic cough diagnosed over 7 years at a UK cough clinic; com-
plete resolution was observed in 14% of the patients, whereas 60%
had worsening or no improvement of cough over time. In a postal
questionnaire study by Koskela et al.,12 a 5-year prognosis was
examined in 68 unselected patients with chronic cough in Finland;Table 2
Comparison of the HARQ scores between chronic persistent cough and remitted cough g
Within the last month, how did the following problems affect you?
Q1. Hoarseness or a problem with your voice
Q2. Clearing your throat
Q3. The feeling of something dripping down the back of your nose or throat
Q4. Retching or vomiting when you cough
Q5. Cough on first lying down or bending over
Q6. Chest tightness or wheeze when coughing
Q7. Heartburn, indigestion, stomach acid coming up
Q8. A tickle in your throat, or a lump in your throat
Q9. Cough with eating (during or soon after meals)
Q10. Cough with certain foods
Q11. Cough when you get out of bed in the morning
Q12. Cough brought on by singing or speaking
Q13. Coughing more when awake rather than asleep
Q14. A strange taste in your mouth
Total HARQ score
HARQ, Hull Airway Reflux Questionnaire.
Each item in the HARQ is scored between 0 and 5 (0 ¼ no problem; 5 ¼ severe/frequenand the proportion of continuing impairment in cough-specific
quality of life (defined as less than 1.3 points’ improvement in the
Leicester Cough Questionnaire [LCQ] scores) was 47%.12 We found
that cough persisted in about 20% of patients with chronic cough
after 4 years of observation following systematic assessment and
treatments, which is lower than the persistence rates reported in
these 2 studies.11,12 These findings are not comparable to each
other, because patients characteristics and endpoint definitions
were different. However, they altogether suggest that cough may
persist for several years in a considerable proportion of patients
with chronic cough, even after systematic management at
specialist clinics. Therefore, further cohort investigation is war-
ranted for more precisely understanding longitudinal outcomes in
patients with chronic cough.
Predictors for cough persistence in patients with chronic cough
are largely unknown. The UK study did not aim to examine baseline
predictors for the cough persistence.11 In the Finnish study,12
continuing regular cough was significantly associated with the
presence of chronic rhinitis, gastroesophageal reflux disease
(GERD), and mild histamine airway hyper-responsiveness, but also
with cough responsiveness to hypertonic saline at baseline, sug-
gesting a patient's clinical trait may predict the persistence of
cough. In the present study, several cough characteristics, such as a
family history of chronic cough, cold air-sensitive cough, or reflux-
associated cough, were found as potential predictors for cough
persistence. Although all above-mentioned findings are not
conclusive because the baseline measurements were heteroge-
neous between studies, these findings suggest that cough should be
more characterized in further cohort studies of cough.
In this study, some parameters related to reflux cough, such as
cough with eating or cough with certain foods, scored significantly
higher in patients with chronic persistent cough than in patients
with remitted cough (Table 2). Our findings should be carefully
interpreted, as reflux-associated cough was merely evaluated by
the questionnaire but not by objective tests. However, we speculate
that esophageal diseases such as dysmotility or airway refluxmight
underlie the cough persistence,20e22 and proper identification and
control of the condition could be clinically useful. In a recent study
of 312 patients with subacute or chronic cough in Japan, about half
of the patients had GERD symptoms as measured by the Frequency
Scale for Symptoms of Gastroesophageal reflux, and the presence of
GERD was significantly associated with a lower rate of treatment
response, longer cough duration, more time until cough alleviation,
and also poorer cough-specific quality of life.23 In a study of 172
patients with cough variant asthma, gastroesophageal dysmotilityroups.
Chronic persistent cough Remitted cough p value
1.7 ± 1.7 1.8 ± 1.7 0.62
3.1 ± 1.5 2.9 ± 1.6 0.39
1.9 ± 1.9 2.1 ± 1.8 0.48
1.8 ± 1.7 1.7 ± 1.7 0.70
1.7 ± 1.8 1.7 ± 1.7 0.94
2.3 ± 2.0 2.0 ± 1.5 0.22
2.0 ± 1.9 2.0 ± 1.5 0.66
3.1 ± 1.7 3.0 ± 1.6 0.91
2.3 ± 1.8 1.7 ± 1.6 0.025
1.7 ± 1.9 1.1 ± 1.5 0.021
1.9 ± 1.7 2.0 ± 1.8 0.85
2.8 ± 1.9 2.5 ± 1.7 0.14
2.8 ± 1.8 2.9 ± 1.7 0.89
1.1 ± 1.5 0.9 ± 1.5 0.44
30.2 ± 13.5 28.1 ± 13.6 0.28
t problems), with total score of 0e70 (from 14 items).
Fig 2. Potential predictors for chronic persistent cough (vs. remitted cough) in patients with chronic cough. Adjusted odds ratios (95% confidence interval (CI)) for chronic persistent
cough (vs. remitted cough) were calculated in multivariate logistic regression analyses with adjustment for parameters with p values less than 0.1 in univariate analyses. HARQ, Hull
Airway Reflux Questionnaire.
S.-Y. Kang et al. / Allergology International 69 (2020) 588e593592symptoms domain, but not acid reflux symptoms, was the signifi-
cant predictor of impaired cough-specific quality of life.24 These
findings suggest that more attention should be paid to reflux-
associated cough in patients with persistent cough.
Potential relevance of a cough trigger or hypersensitivity pattern
has been suggested in several studies of patients with chronic
cough. In studies of patients with prolonged or chronic cough in
Japan, cold air, as a cough trigger, was significantly associated with
the diagnosis of cough variant asthma, or its biomarkers such as
methacholine airway responsiveness and fractional exhaled nitric
oxide levels.25,26 Similarly, in a Finnish community population-
based study of 421 subjects with current cough, subfreezing air as
a cough trigger predicted current asthma-associated cough.27
Meanwhile, in a cross-sectional study in Sweden, the number of
chemical sensitivity (as a cough trigger) was positively associated
with poorer quality of life in patients with chronic cough.28 In a
recent multi-center study of Korean patients, the number of cough
triggers was significantly higher in patients with chronic refractory
cough than those with unselected chronic cough.29 However, none
of previous studies have examined the relevance of a cough trigger
or hypersensitivity pattern in relation to longitudinal persistence of
cough.
The present study also indicates that there may be a familial
association with persistence in cough (aOR: 4.27 [95% CI:
1.35e9.89]; Fig. 2). Interestingly, in a Finnish communityFig. 3. Potential predictors for chronic persistent cough (vs. intermittent cough and remitt
cough (left) and cold air-sensitive cough (right) (B) Scores for ‘Cough with eating’ (left) and
presented as percentage, or mean with standard deviation. p values were determined by Cpopulation study by L€atti et al., family history of chronic cough was
significantly associated with current daily cough (vs. no current
cough).30 Although it is rare, a genetic inheritance was reported for
Australian families with chronic cough and GERD.31 These findings
altogether suggest a potential role for genetic inheritance, or
common environmental factors in rendering cough more persis-
tent, which warrant further investigation.
In the present study, several baseline indicators for common
cough-associated conditions, such as rhinosinusitis symptoms,
methacholine airway hyper-responsiveness, or sputum eosino-
philia,4 were not significantly associated with cough persistence.
However, our findings do not refute the clinical relevance of these
cough-associated conditions, because all study participants had
undergone systematic assessment and treatment according to the
anatomic diagnostic protocols.3,4
This study mainly focused on the comparison between chronic
persistent cough and remitted cough patient groups. However,
there were “intermediate cough” subgroups (20.4% of the partici-
pants), as described in Results, which did not clearly fit into any of 2
main groups. Due to small numbers of patients per each subgroup,
they were arbitrarily classified as a single intermediate group, and
then compared with chronic persistent cough and remitted cough
groups. Four baseline parameters significantly differed among 3
groups, including family history of chronic cough, cold air-sensitive
cough, cough with eating, and cough with certain foods, but alsoed cough) in patients with chronic cough (A) Proportions of family history of chronic
‘Cough with certain foods’ (right) in the Hull Airway Reflux Questionnaire. Values are
hi-squared test or 1-way ANOVA.
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(Fig. 3A, B; Supplementary Table 3, 4), suggesting potentially
different roles of each parameter in cough persistence. However,
larger cohort studies are warranted to clarify their relevance.
There are several limitations that should be considered when
interpreting our findings. First, the persistence of cough was self-
reported, which may be prone to a recall bias. Second, although
we employed structured questionnaires to define cough persis-
tence, an approach utilizing validated scales, such as the LCQ, may
have beenmore appropriate, as theminimal important difference is
known as 1.3 points.32 However, it is unknown whether the LCQ
holds its original validity when utilized in a telephone interview.
Third, we could not fully obtain treatment details and reasons to
continue (or stop) their medications over 4 years. Finally, we could
not assess longitudinal changes in baseline clinical parameters, and
thus the possibility should not be overlooked that causative factors
of cough (such as GERD, eosinophilic bronchitis, or atopic cough)
may remain uncontrolled at the time of follow-up survey.We found
several baseline parameters that were significantly associated with
cough persistence at 4 years, but their causal relationships warrant
confirmation in prospective longitudinal cohort studies.
The strength of our present study includes a relatively high
response rate (77.3%), enabling a follow-up of 323 patients at 4
years, which is much larger than previous studies.11,12 Our findings
are valuable addition to the literature on longitudinal epidemiology
of chronic cough, and suggest clues for further investigations
In conclusion, cough may persist in about 20% of patients after 4
years of observation following systematic assessment and treat-
ments. Several cough characteristics, such as a family history of
chronic cough, cough trigger pattern, or reflux cough may be
potentially associated with cough persistence. Larger prospective
cohort studies are warranted to further understand the long-term
prognosis and confirm predictors of persistence in patients with
chronic cough.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.alit.2020.03.012.
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